H
Huakan Bio
The biomimetic 3D technology product that focuses on solving customized, large-scale, automated, and high-quality stem cell culture and expansion processes
About Huakan Bio
Beijing Huakan Biotechnology Co., Ltd., also known as CytoNiche, is a company that emerged in 2018 from a research team at Tsinghua University's School of Medicine. The company was co-founded by CEO Liu Wei, Chief Scientist Professor Du Yanan, and Dr. Yan Xiaojun, who is the CTO. The core technology, which originated from scientific and technological achievements at Tsinghua University, is centered on a proprietary 3D micro-scaffold technology.
Huakan Bio operates in the upstream biopharmaceutical market, providing solutions for the large-scale manufacturing of cells. The company's business model has evolved from solely selling products to a more integrated "product + service" approach, establishing a Contract Development and Manufacturing Organization (CDMO) platform. Its client base includes companies and research institutions in gene and cell therapy, vaccine production, protein product development, and regenerative medicine. Huakan Bio also serves emerging markets such as organoids and cultivated meat.
The company’s flagship offering is the 3D FloTrix® automated process system for large-scale cell production. This system encompasses a suite of products, including the proprietary 3D TableTrix® Microcarrier Tablets. These dissolvable microcarriers are a key component, having received pharmaceutical excipient qualifications from both the U.S. FDA and China's NMPA. The full system includes bioreactors, cell harvesting equipment, and reagents designed to automate the entire cell production workflow from inoculation and expansion to harvesting and formulation. This technology significantly reduces the need for manual labor, production space, and material consumption compared to traditional 2D cell culture methods.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Dongcheng District, China
- Employees
- 1
- Open positions
- None listed
- Dealroom signal
- 57.4/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Technology
- 3D Technology, Deep Tech
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANTOther financing | Jul 2023 | $10K | — | brics-inno.com | ↗ |
| SERIES B✓Equity / VC | Mar 2022 | $41M | $165M | Sinopharm Healthcare Fund · Aibo · Gaorong Ventures · Yijing Capital | ↗ |
Growth signals
Latest recorded traffic for Huakan Bio is 2K monthly website visits, up 81.8% over the last three months. Huakan Bio's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Huakan Bio in the Dongcheng District ecosystem
The Huakan Bio office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
brics-inno.com
Series A11 investors entered at this stage
- GMGuoke Jiahe (Beijing) Investment Management
- CCCASH Capital
Detong Capital- SFSinopharm Healthcare Fund
- AIAibo
Gaorong Ventures
Yijing Capital- KEKexing
Shanghai CICC Capital- H(Hongtai Fund (Shenzhen)
- YCYuanhui Capital
Other known investors2 additional known investors
Tsinghua University- HAHongtai Aplus
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Huakan Bio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Huakan Bio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








